Variable involvement of the perivascular retinal tissue in carbonic anhydrase inhibitor-induced relaxation of porcine retinal arterioles in vitro

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4688-4693

  Kehler, Anne Katrine ^a   Holmgaard, Kim ^a   Hessellund, Anders ^a   Aalkjaer, Christian ^b   Bek, Toke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; ETHYL BROMOPYRUVATE; METHYL BROMOPYRUVATE; UNCLASSIFIED DRUG; SULFONAMIDE; THIOPHENE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; ANIMAL; ARTERIOLE; DRUG EFFECT; PHYSIOLOGY; SWINE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETAZOLAMIDE; ANIMALS; ARTERIOLES; CARBONIC ANHYDRASE INHIBITORS; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; RETINAL ARTERY; SULFONAMIDES; SWINE; THIOPHENES; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 35748930567     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0048     Document Type: Article

References (26)

1. Sugrue MF. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther. 1996;12:363-376.
2. Rassam SMB, Patel V, Kohner EM. The effect of acetazolamide on the retinal circulation. Eye. 1993;7:697-702.
3. Josefsson A, Sigurdsson SB, Bang K, Eysteinsson T. Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries. Exp Eye Res. 2004;78:215-221.
4. Reber F, Gersch U, Funk RHW. Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular pH and increase of intracellular pH in rat retinal organ culture. Graefes Arch Clin Exp Ophthalmol. 2003;241:140-148.
5. Stefánsson E, Jensen PK, Eysteinsson T, et al. Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors. Invest Ophthalmol Vis Sci. 1999;40:2756-2761.
6. Pedersen DB, Jensen PK, la Cour M, et al. Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels. Graefes Arch Clin Exp Ophthalmol. 2005;243:163-168.
7. Kiss B, Dallinger S, Findl O, Rainer G, Eichler H, Schmetterer L. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide. Am J Physiol. 1999;45:1661-1667.
8. Wistrand PJ. Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland. EXS. 2000;90:413-424.
9. Inoue J, Oka M, Aoyama Y, et al. Effects of dorzolamide hydrochloride on ocular tissues. J Ocul Pharmacol Ther. 2004;20:1-13.
10. Nagelhus EA, Mathiisen TM, Bateman AC, et al. Carbonic anhydrase XIV is rich in specific membrane domains of retinal pigment epithelium, Müller cells, and astrocytes. Proc Natl Acad Sci USA. 2005;102:8030-8035.
11. Holmgaard K, Aalkjær C, Lambert JDC, Hessellund A, Bek T. The relaxing effect of perivascular tissue on porcine retinal arterioles in vitro is mimicked by N-Methyl-D-Aspartate and is blocked by prostaglandin synthesis inhibition. Acta Ophthalmol Scand. In press.
12. Hessellund A, Jeppesen P, Aalkjaer C, Bek T. Characterization of vasomotion in porcine retinal arterioles. Acta Ophthalmol Scand. 2003;81:278-282.
13. Pickkers P, Garcha RS, Schachter M, Smits P, Hughes A. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension. 1999;33:1043-1048.
14. Harris A, Arend O, Arend S, Martin B. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta Ophthalmol Scand. 1996;74:569-572.
15. Dollery CT, ed. Therapeutic Drugs. 2nd ed. Edinburgh, Scotland, UK: Churchill Livingstone; 1991.
16. ca channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol. 2001;132:443-450.
17. Berg JT, Ramanathan S, Gabrielli MG, Swenson ER. Carbonic anhydrase in mammalian vascular smooth muscle. J Histochem Cytochem. 2004;52:1101-1106.
18. Hessellund A, Aalkjaer C, Bek T. Effect of acidosis on isolated porcine retinal vessels. Curr Eye Res. 2006;31:427-434.
19. Kobayashi M, Naito K. Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent (in Japanese). Nippon Yakurigakui. 2000;115323-328.
20. Martens-Lobenhoffer J, Banditt P. Clinical pharmacokinetics of dorzolamide. Clin Pharmacokinet. 2002;41:197-205.
21. Grunwald JE, Mathur S, DuPont J. Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta Ophthalmol Scand. 1997;75:236-238.
22. Pillunat LE, Bohm AG, Koller AU, Schmidt KG, Klemm M, Richard G. Effect of topical dorzolamide on optic nerve head blood flow. Graefes Arch Clin Exp Ophthalmol. 1999;237:495-500.
23. Faingold D, Hudson C, Flanagan J, et al. Assessment of retinal hemodynamics with the Canon laser blood flowmeter after a single dose of 2% dorzolamide hydrochloride eyedrops. Can J Ophthalmol. 2004;39:506-510.
24. Martinez A, Gonzalez F, Capeans C, Perez R, Sanchez-Salorio M. Dorzolamide effect on ocular blood flow. Invest Ophthalmol Vis Sci. 1999;40:1270-1275.
25. Costagliola C, Campa C, Parmeggiani F, et al. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0,5% timolol. Br J Clin Pharmacol. 2007;63:376-379.
26. Fuchsjäger-Mayrl G, Wally B, Rainer G, et al. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension. Br J Ophthalmol. 2005;10:1293-1297.